Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects
clinical trial
Press Enter · cited answer in seconds
0 sources
Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects
Summary
Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects is a clinical trial[1].
Key Facts
- Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects is in the country of Singapore[2].
- Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects's instance of is recorded as clinical trial[3].
- Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects's start time is recorded as +2020-08-04T00:00:00Z[4].
- Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects's end time is recorded as +2021-01-00T00:00:00Z[5].
- Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects's number of participants is recorded as {'unit': '1', 'amount': '+92'}[6].
- Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects's title is recorded as A Phase 1/2 Randomised, Double Blinded, Placebo Controlled, Ascending Dose Study to Assess the Safety, Tolerability, and Immunogenicity of ARCT-021 in Healthy Adult Subjects[7].
- Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q24564698', 'amount': '+21'}[8].
- Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects's ClinicalTrials.gov ID is recorded as NCT04480957[9].
- Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q24564698', 'amount': '+80'}[10].
- Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects's clinical trial phase is recorded as phase I clinical trial[11].
- Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects's clinical trial phase is recorded as phase II clinical trial[12].